MKI67 and neuroendocrine carcinoma: There is also a World Health Organization (WHO) classification of NETs that groups them into well-differentiated Grade 1 and Grade 2 tumors (NET G1 and NET G2), and poorly differentiated Grade 3 tumors, neuroendocrine carcinomas (NEC G3), according to their mitotic or Ki-67 indices [9].